BPG is committed to discovery and dissemination of knowledge
Citation
Wishahi M. Erdafitinib and checkpoint inhibitors for first-line and second-line immunotherapy of hepatic, gastrointestinal, and urinary bladder carcinomas: Recent concept. World J Hepatol 2024; 16(4): 490-493 [PMID: 38689741 DOI: 10.4254/wjh.v16.i4.490]
Please LOGIN to submit a new comment.